How Wegovy Helps with Weight Loss: What the Evidence Shows

What is actually happening in your body when Wegovy works?

GLP-1 (glucagon-like peptide-1) is a hormone your gut releases after you eat. It tells the brain you have had enough, encourages the pancreas to release insulin, and slows the passage of food through the stomach. Most people with obesity produce GLP-1 normally, but the signal fades quickly. Semaglutide is a synthetic version of that hormone, engineered to stay active for around a week, which is why a single weekly injection can sustain the appetite-reducing effect day to day.

The practical result is that meals feel more filling faster. Many people on Wegovy describe finding it genuinely difficult to finish portions they would previously have eaten without thinking. That is not discipline, it is the medicine doing its job at a neurological level. Food noise, the persistent background pull towards eating when you are not truly hungry, tends to quieten. For a thorough breakdown of the weight-loss mechanism specifically, this page on exactly how Wegovy drives weight reduction covers the physiology in more detail.

Gastric emptying slows too, which contributes to that sustained fullness and also explains the most common side effects: nausea, constipation, and indigestion, particularly in the first few weeks. The NHS medicines page for semaglutide gives a clear rundown of what to expect and what to watch for.

Who Wegovy is most likely to help, and who it may not suit

The licensed criteria in the UK are a BMI of 30 or above, or 27 or above alongside at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. A BMI figure alone does not guarantee that Wegovy is the right choice, a prescriber considers the full clinical picture, including other medicines you take and any conditions that may affect tolerability.

Wegovy is not recommended during pregnancy, while breastfeeding, or for anyone trying to conceive. It is not licensed for people under 18. There are also specific contraindications (a history of medullary thyroid carcinoma or MEN2 syndrome, for example) that a prescriber will ask about before any prescription is issued. Our Wegovy overview page sets out the full eligibility picture, and if you have questions about your specific situation our FAQs are a good starting point.

One thing our prescribers are asked fairly regularly: does Wegovy help with anything beyond weight? There is now approved evidence for cardiovascular risk reduction in eligible adults. Semaglutide has also received conditional MHRA approval for a form of fatty liver disease (MASH) as of July 2026, though those indications are separate from weight management and not the basis on which nume prescribes. What does wegovy help with, beyond the scales, is genuinely an active area of research.

Making the medicine work, what you do alongside it matters

Wegovy is licensed alongside a reduced-calorie diet and increased physical activity. That is not a caveat to be skimmed over. The STEP 1 trial, published in the New England Journal of Medicine, showed roughly 15% average weight loss over 68 weeks, but participants were also receiving lifestyle support. The medicine lowers the barrier; the habits you build during treatment are what sustain results over time.

Protein intake, hydration, and some form of resistance activity become particularly relevant because weight lost on GLP-1 treatment includes muscle as well as fat. Preserving muscle mass matters for metabolism and long-term health. Your prescriber can advise on this, and practical steps that support Wegovy's effect are worth reading before you start. Some people also notice changes in sleep and digestion, if you are curious about the wider effects, how Wegovy may affect sleep is covered separately.

A personal note from the kind of question we hear most weeks: people often worry that the medicine is doing the work and they are not. That framing is not quite right. You are choosing to stay consistent, to manage side effects, to adjust what is on your plate. That is effort. The medicine changes the hormonal conditions you are working in. Both things are true.

Cost, access, and what a prescription actually involves

Wegovy is available on the NHS via specialist weight management services under NICE guidance (TA875), though waiting lists are long and the criteria are specific. Private treatment through a regulated pharmacy is the route for people who do not meet NHS thresholds or prefer not to wait. It is worth understanding what a legitimate private prescription includes: clinical assessment, prescriber review, the medicine itself, and ongoing aftercare. A clear breakdown of what Wegovy costs privately in the UK (and what to check before paying) is on our pricing page.

At nume, every consultation is read by a GPhC-registered Independent Prescriber, not software. Order before noon on a working day and, once a prescriber approves your assessment, your treatment goes out the same afternoon, tracked, in plain packaging, arriving the next working day. There are no subscriptions. Every repeat order is reviewed again from scratch. If you want to check whether Wegovy is clinically suitable for you, the right place to start is a free consultation with our prescribers. You can also read more about how nume works and the clinical standards we hold ourselves to before you decide anything.